semaglutide for heart disease GLP-1 agonists like Ozempic may reduce cardiovascular events by 20% FDA Approves Wegovy to Reduce

There arent specific foods or drinks you need to avoid while using Wegovy, though some can make side effects worse

Qi Y, Zhang J, Zhang Y, et al

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodiumglucose cotransporter-2 inhibitors (SGLT2is) both provide cardiovascular benefit, although their clinical profiles differ as SGLT2 inhibitors have shown greater reductions in HF hospitalization, whereas GLP-1 receptor agonists appear particularly effective in reducing atherosclerotic events such as stroke [5, 6]

Participants with low MVZ alone were leaner than those with high MFI alone, while participants with AMC were the most metabolically burdened

Arch Tierernahr

Aparicio E, Jardi C, Bedmar C, et al